ReviewAsian spine journal2026
Impact of sarcopenia on outcomes of percutaneous vertebroplasty and kyphoplasty: a comprehensive meta-analysis.
Review in Asian spine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis meta-analysis evaluated the impact of sarcopenia on the efficacy and safety of percutaneous vertebroplasty and kyphoplasty in patients with osteoporotic vertebral compression fractures.
methodsFollowing PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines, a systematic literature search was conducted to identify studies comparing outcomes between patients with and without sarcopenia undergoing vertebroplasty or kyphoplasty. Twelve studies involving 1,786 patients were included. The primary outcomes were pain (measured using the Visual Analog Scale), refractures, disability (using the Oswestry Disability Index), length of hospital stay, and mortality rates. Heterogeneity was assessed using the I2 statistic. Mean differences (MDs) and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, applying a random-effects model when heterogeneity was present.
resultsPatients with sarcopenia experienced significantly higher pain (MD, 0.82; 95% CI, 0.47-1.17; p<0.00001), greater disability (MD, 5.70; 95% CI, 4.54-6.87; p<0.00001), and increased refracture risk (OR, 2.58; 95% CI, 1.13-5.89; p=0.02) compared with those without sarcopenia. Length of hospital stay was also longer, and mortality rates were significantly higher in the sarcopenia group.
conclusionsSarcopenia is an important risk factor for adverse outcomes after vertebroplasty and kyphoplasty. A systematic assessment of sarcopenia and the development of tailored perioperative strategies may help mitigate these risks and improve patient outcomes (PROSPERO registration no., CRD42024628263).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.